Cancer stem cell (CSC) resistance drivers
M Najafi, K Mortezaee, J Majidpoor - Life sciences, 2019 - Elsevier
Cancer stem cells (CSCs) are a population of self-renewal cells with high tumorigenic
potency. CSCs can adopt easily with changes in the nearby milieu, and are more resistant to …
potency. CSCs can adopt easily with changes in the nearby milieu, and are more resistant to …
Sorting through the extensive and confusing roles of sortilin in metabolic disease
Sortilin is a post-Golgi trafficking receptor homologous to the yeast vacuolar protein sorting
receptor 10 (VPS10). The VPS10 motif on sortilin is a 10-bladed β-propeller structure …
receptor 10 (VPS10). The VPS10 motif on sortilin is a 10-bladed β-propeller structure …
Fluid biomarkers in frontotemporal dementia: past, present and future
IJ Swift, A Sogorb-Esteve, C Heller… - Journal of Neurology …, 2021 - jnnp.bmj.com
The frontotemporal dementia (FTD) spectrum of neurodegenerative disorders includes a
heterogeneous group of conditions. However, following on from a series of important …
heterogeneous group of conditions. However, following on from a series of important …
[PDF][PDF] Tumor-initiating stem cell shapes its microenvironment into an immunosuppressive barrier and pro-tumorigenic niche
Tumor-initiating stem cells (TSCs) are critical for drug resistance and immune escape.
However, the mutual regulations between TSC and tumor microenvironment (TME) remain …
However, the mutual regulations between TSC and tumor microenvironment (TME) remain …
Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia
M Kurnellas, A Mitra, T Schwabe, R Paul… - Journal of Translational …, 2023 - Springer
Background Heterozygous loss-of-function mutations in the progranulin (PGRN) gene
(GRN) cause a reduction in PGRN and lead to the development of frontotemporal dementia …
(GRN) cause a reduction in PGRN and lead to the development of frontotemporal dementia …
Biology of cancer; from cellular and molecular mechanisms to developmental processes and adaptation
IG Motofei - Seminars in Cancer Biology, 2022 - Elsevier
Cancer research has been largely focused on the cellular and molecular levels of
investigation. Recent data show that not only the cell but also the extracellular matrix plays a …
investigation. Recent data show that not only the cell but also the extracellular matrix plays a …
Breast cancer stem cells: A review of their characteristics and the agents that affect them
The evolving concept that cancer stem cells (CSCs) are the driving element in cancer
development, evolution and heterogeneity, has overridden the previous model of a tumor …
development, evolution and heterogeneity, has overridden the previous model of a tumor …
Microglial progranulin: involvement in Alzheimer's disease and neurodegenerative diseases
A Mendsaikhan, I Tooyama, DG Walker - Cells, 2019 - mdpi.com
Neurodegenerative diseases such as Alzheimer's disease have proven resistant to new
treatments. The complexity of neurodegenerative disease mechanisms can be highlighted …
treatments. The complexity of neurodegenerative disease mechanisms can be highlighted …
PGRN−/− TAMs-derived exosomes inhibit breast cancer cell invasion and migration and its mechanism exploration
S Yue, X Ye, T Zhou, D Gan, H Qian, W Fang, M Yao… - Life Sciences, 2021 - Elsevier
Breast cancer is one of the most malignant diseases world-wide and ranks the first among
female cancers. Progranulin (PGRN) plays a carcinogenic role in breast cancer, but its …
female cancers. Progranulin (PGRN) plays a carcinogenic role in breast cancer, but its …
The membrane protein sortilin is a potential biomarker and target for glioblastoma
Simple Summary Glioblastoma (GBM) is the most lethal adult primary brain tumor, and has
no cure. This study investigated the membrane protein sortilin as a prognosis biomarker for …
no cure. This study investigated the membrane protein sortilin as a prognosis biomarker for …